Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12383491rdf:typepubmed:Citationlld:pubmed
pubmed-article:12383491lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0302908lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0286738lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0292818lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0525005lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:12383491lifeskim:mentionsumls-concept:C0205352lld:lifeskim
pubmed-article:12383491pubmed:issue1lld:pubmed
pubmed-article:12383491pubmed:dateCreated2002-10-17lld:pubmed
pubmed-article:12383491pubmed:abstractTextA simple reversed-phase liquid chromatographic method has been developed to determine protease inhibitors concentrations in plasma. Plasma samples (250 micro l) containing protease inhibitors were prepared by a simple deproteinization (recovery: 92, 91, 91 and 90.5% for ritonavir, saquinavir, nelfinavir and M8 nelfinavir metabolite, respectively). Chromatography was accomplished using a Hypersil octadecylsilyl column (100 x 4.6 mm I.D.) and a mobile phase composed of acetonitrile, tetrahydrofuran and dihydrogenophosphate buffer (pH 4) (32:10:58, v/v). Ultraviolet detection at 210 nm was used. The limit of detection was 200 ng/ml for ritonavir, saquinavir, nelfinavir and M8 nelfinavir metabolite. Calibration curves were linear up to 20000 ng/ml, with correlation coefficients better than 0.997 for all compounds. Intra- and inter-day coefficients of variation of the assay were <or=6% for all compounds. This method was used to analyse protease inhibitors plasma concentrations after oral administration within the framework of therapeutic drug monitoring and pharmacokinetic studies in AIDS patients.lld:pubmed
pubmed-article:12383491pubmed:languageenglld:pubmed
pubmed-article:12383491pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12383491pubmed:citationSubsetIMlld:pubmed
pubmed-article:12383491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12383491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12383491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12383491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12383491pubmed:statusMEDLINElld:pubmed
pubmed-article:12383491pubmed:monthNovlld:pubmed
pubmed-article:12383491pubmed:issn1570-0232lld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:FavettaPPlld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:BleyzacNNlld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:CoudraySSlld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:AulagnerGGlld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:BourhisYYlld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:JanolyAAlld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:GagneuM CMClld:pubmed
pubmed-article:12383491pubmed:authorpubmed-author:OgerIIlld:pubmed
pubmed-article:12383491pubmed:issnTypePrintlld:pubmed
pubmed-article:12383491pubmed:day15lld:pubmed
pubmed-article:12383491pubmed:volume780lld:pubmed
pubmed-article:12383491pubmed:ownerNLMlld:pubmed
pubmed-article:12383491pubmed:authorsCompleteYlld:pubmed
pubmed-article:12383491pubmed:pagination155-60lld:pubmed
pubmed-article:12383491pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:meshHeadingpubmed-meshheading:12383491...lld:pubmed
pubmed-article:12383491pubmed:year2002lld:pubmed
pubmed-article:12383491pubmed:articleTitleSimple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma.lld:pubmed
pubmed-article:12383491pubmed:affiliationPharmacy Department, Debrousse Hospital, 29 Rue Soeur Bouvier, 69005, Lyon, France.lld:pubmed
pubmed-article:12383491pubmed:publicationTypeJournal Articlelld:pubmed